Judah Frommer Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
19
Avg Return
Past Year
Past Year
62%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
71.4%
Neutral
28.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Consumer Staples
Healthcare
Consumer Discretionary
Specialty Retail
Consumer Staples
Discount Stores
Food Distribution
Grocery Stores
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Care Facilities
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $17 |
66%
upside
| 3 | +20% |
0
%
| 6 Mar ‘26 4 days ago |
|
|
|
Overweight
Maintained
| $201 |
15%
upside
| 2 | +4.8% |
0
%
| 3 Mar ‘26 7 days ago |
|
|
|
Overweight
Initiated
| $28 |
98%
upside
| 1 | -13% |
0
%
| 3 Mar ‘26 7 days ago |
|
|
|
Equal-Weight
Reinstated
| $34 |
22%
upside
| 1 | – |
–
| 16 Feb ‘26 22 days ago |
|
|
|
Overweight
Maintained
| $145 |
26%
upside
| 4 | +265% |
0
%
| 9 Jan ‘26 2 months ago |
|
|
|
Equal-Weight
Downgraded
| $19 |
27%
downside
| 2 | -54% |
0
%
| 6 Jan ‘26 2 months ago |
|
|
|
Overweight
Initiated
| $36 |
43%
upside
| 1 | +21% |
0
%
| 1 Dec ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $19 |
65%
upside
| 2 | +26% |
0
%
| 14 Nov ‘25 3 months ago |
|
|
|
Equal-Weight
Maintained
| $26 |
33%
upside
| 1 | – |
–
| 2 Jul ‘25 8 months ago |
|
|
|
Equal-Weight
Maintained
| $129 |
0%
downside
| 2 | – |
–
| 5 Jun ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $43 |
37%
upside
| 2 | +29% |
0
%
| 9 May ‘25 10 months ago |
|